Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | EGFR Antisense DNA |
| Synonyms | |
| Therapy Description |
EGFR antisense DNA is synthetic DNA that runs antisense to the EGFR sequence and suppresses endogenous EGFR expression, potentially resulting in decreased tumor cell proliferation (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| EGFR Antisense DNA | EGFR Inhibitor (Pan) 63 | EGFR antisense DNA is synthetic DNA that runs antisense to the EGFR sequence and suppresses endogenous EGFR expression, potentially resulting in decreased tumor cell proliferation (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT00903461 | Phase Ib/II | EGFR Antisense DNA | Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma | Terminated | USA | 0 |